← Leaderboards
Dima A Hammoud
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageBrainPositron-Emission TomographyProtocols DocumentationInfectionHiv InfectionsLigandsFunctional DisorderAnimalsLabelRadiolabeledLungUptakeScanningAnimal ModelIn VivoNeurotransmittersViral ProteinsMagnetic Resonance ImagingNeuron LossMicropetExposure ToNanobodiesImaging Modality
Grant awards (28)
Imaging of fungal infections$0
ZIA · FY2025 · CL · contact PI
Molecular imaging of viral infections$0
ZIA · FY2025 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2024 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2024 · CL · contact PI
Molecular imaging of viral infections$0
ZIA · FY2024 · CL · contact PI
Molecular imaging of viral infections$0
ZIA · FY2023 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2023 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2023 · CL · contact PI
Molecular imaging of viral infections$0
ZIA · FY2022 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2022 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2022 · CL · contact PI
Molecular imaging of viral infections$0
ZIA · FY2021 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2021 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2021 · CL · contact PI
Molecular imaging of viral infections$0
ZIA · FY2020 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2020 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2020 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2019 · CL · contact PI
Molecular Imaging of neuroHIv using animals models of disease$0
ZIA · FY2019 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2019 · CL · contact PI
Molecular Imaging of neuroHIv using animals models of disease$0
ZIA · FY2018 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2018 · CL · contact PI
Imaging of fungal infections$0
ZIA · FY2018 · CL · contact PI
Molecular Imaging of neuroHIv using animals models of disease$0
ZIA · FY2017 · CL · contact PI
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients$0
ZIA · FY2017 · CL · contact PI
Molecular Imaging of neuroHIv using animals models of disease$0
ZIA · FY2016 · CL · contact PI
Neurovascular MRI in the Assessment of HIV-Associated Neurocognitive Disorders$0
ZIA · FY2014 · CL · contact PI
Neurovascular MRI in the Assessment of HIV-Associated Neurocognitive Disorders$0
ZIA · FY2012 · CL · contact PI